However, hypoglycemia is the most common complication in people with endogenous insulin deficient diabetes and typically results from therapeutic hyperinsulinemia, compromised symptomatic responses, and impaired physiologic glucose counterregulatory defenses (Cryer 2012). This evidence concerns the gene INS and Hypoglycemia.